Understanding Peptides: Safety, Legality, and the Push for Accessibility in the U.S.

What if the future of health optimization, recovery, and longevity isn’t just about new therapies — but about understanding the science, safety, and regulation behind what we put into our bodies? In this episode of The Better Body Lab Podcast, we explore the evolving landscape of research peptides and how innovation, policy, and personal responsibility intersect within the human ecology of health.

Together, we unpack what peptides are, how they function as biological signaling molecules, and why growing public interest has outpaced scientific validation and regulatory clarity. We examine the current U.S. legal environment, including discussions around accessibility, compounding practices, and the realities of the FDA approval process. Our conversation highlights critical safety considerations such as supply chain transparency, third-party testing, and the difference between anecdotal outcomes and controlled human research.

We also explore how curiosity, resilience, and foundational habits — including sleep, nutrition, movement, and stress regulation — remain central to sustainable performance and wellbeing. This episode offers a grounded, evidence-informed perspective for anyone navigating wellness trends, longevity strategies, or emerging performance tools.

For information about where Dr. Taryn and Mike source their peptides and the companies they co-founded, visit:

https://bioaccessconnect.com/

https://bodycaremd.com/

Key Timestamps:
00:00 Peptides Explained

04:00 Legal Landscape & Policy Debate

10:02 Safety Risks & Regulatory Pathways

17:03 Third-Party Testing & Consumer Trust

21:13 Research Gaps & Evidence Limits

24:39 Emerging Therapeutic Interest

30:04 Final Reflections

*Audio or video clips referenced or discussed in this episode that originate from The Joe Rogan Experience remain the property of their respective owners. All rights belong to The Joe Rogan Experience. Such material is used for commentary, educational discussion, and informational purposes only.

Follow The Better Body Lab Podcast here:

Instagram: https://www.instagram.com/thebetterbodylabpodcast/

Facebook: https://www.facebook.com/profile.php?id=61582408795363

Youtube: https://www.youtube.com/@TheBetterBodyLabPodcast

TikTok: https://www.tiktok.com/@thebetterbodylabpodcast

Dr. Taryn Marie: www.resilience-leadership.com/

Mike Alden: https://www.mikealden.com/ 

Follow Dr. Taryn Marie here: 

Facebook: https://www.facebook.com/DrTarynMarie

Instagram: https://www.instagram.com/drtarynmarie/

Follow Mike Alden here: 

Facebook: https://www.facebook.com/MikeAlden2012

Instagram: https://www.instagram.com/mikealden

Visit:

https://bodycaremd.com/

https://bioaccesslabs.com/

Transcript

SPEAKER_01 0:00

These peptides that are classified for research purposes only, and this is really important, Mike. How much research has been conducted on what these research-only peptides do inside the human body?

SPEAKER_03 0:22

Well, it depends on the peptide itself that we're talking about. Some of these have zero research as it relates to safety. I mean zero. And someone would say, well, why? Like, how is this even how is this stuff even available? Why would anybody even inject it in themselves? Like, it doesn't even make any sense. Like, how could anybody inject something in their body that has zero safety studies as it relates to humans consuming it?

SPEAKER_01 1:10

This is Dr. Taryn Marie and Mike Alden from the Better Body Lab Podcast. And we've got a special episode for you today where we're gonna talk about peptides. And if you've been following along with what's happening in the news and with the FDA and with RFK, you may have noticed that there's a lot of conversation about whether or not research peptides are going to be legalized and what that would mean. And so Mike and I wanted to come to you to bring you a sense of how you can think about what peptides are. Maybe you don't even know what a peptide is. And so we can talk to you about what a peptide is and what this might mean for building a better body, a better mind, and a better life. And fortunately, Mike is our resident uh peptide expert, both in terms of understanding a great deal about peptides themselves. We both have a peptide stack that we use, and he's studied carefully the legal landscape of what might happen in the future. So, Mike, so excited to have this conversation with you.

SPEAKER_03 2:19

Well, thank you. I don't know that I'm a peptide expert, but don't, don't, don't, don't, don't discredit yourself. Yeah, I think you're you do a better job of explaining what peptides are, but uh I certainly have been in this, you know, health and wellness space, dietary supplement space, nutraceutical spaces, people like that that made up Word uh, you know, for a long time and certainly been interested in it my pretty much not only my entire career, but my entire life. So um it's a very interesting time right now uh for the world of peptides. Absolutely.

SPEAKER_01 2:54

I think so. All right, so why don't we start off with what a peptide is? And maybe I'll be the one to do that explanation. You do really, yeah, in layman's and layman's terms. So, all right, so for those of you listening in, I want you to sort of like re-ro rewind back to your high school biology days uh when you learned about nutrition and biology. And what we learned about uh were the building blocks of protein. And the building blocks of protein are amino acids. And as you remember, uh amino acids are made up of peptide chains. And so when we talk about a peptide, it is effectively a medication that has been created in a way that it is tied to a chain of peptides, which are the building blocks of amino acids and ultimately proteins. Something that a lot of people don't know is when we talk about weight loss medications like GLP1s, the branded names for that are Ozempic, Manjaro, uh, WeGovi, things like that. Those are pep, those are peptides. That is a weight loss medication that has been built on a peptide chain. It has been legalized, it has been created by pharmaceutical manufacturers like Eli Lilly and Novo Nordisk. Um, also what we call the non-branded GLP ones, uh, by the name of uh semiglutide or semiglutide or terzeptide or retitrutide. Uh, those are all peptides too uh for weight loss. What we're gonna be talking about today is a specific class of research peptides. And these are things that you may have heard about, like BPC 157, TB500. Um there's a copper, it's called GHKCU. There's thousands of these kinds of research uh peptides. And what's really fascinating is um and I'm and Mike, I want you to say more about this. We typically only have these peptides as a research only uh access, and they're not broadly legalized across the United States. They're not illegal, but they're also not legal. Um so, Mike, could you talk to us a little bit about kind of set the stage what is happening in the world of research peptides right now that people might find fascinating and interesting? And and what does that mean as we're kind of hearing about this idea of like legalization and availability?

SPEAKER_03 5:42

Yeah, I mean, it's a really, really interesting time in the world of um, you know, health and wellness and taking on uh a real interest in your own personal health, right? Agency of your own personal health. And uh it's interesting to have someone like RFK, you know, uh at the head of the HSS, you know, whether or not you are a proponent of his or supporter of his, it doesn't really matter. Uh what he is doing, and just like Trump as well, is really kind of disrupting the status quo, right? Right. Trump obviously politically and and globally and all these all these different things where where Kennedy is really taking aim at some of the things that he believes, whether he's right or wrong, uh, you know, are not good for the American public, you know, like taking dyes out of um out of out of the food supply. You know, one basic thing is, you know, you look at fruit loops, right, uh, here in the United States, or you look at fruit loops in Europe. And if you look at the list of of the ingredients, call them ingredients loosely, in Fruit Loops here, there's probably 40 or 50 different ingredients, where in Europe or other parts of the world, there's like 10, right? And a lot of those things that are here in the United States are designed really to uh you know maintain the shelf life of these products so they can sit on the shelves longer. And that also can go down an entire rabbit hole of government subsidies and and and how things are made and and why they basically stockpile things. So a lot of preservatives and a lot of things that are in our food supply here in the United States just ultimately aren't good for us. So he is, you know, kind of disrupting that world. So from food, and then you know, then they're taking aim at the um uh you know, the pharmaceutical space, right? Uh if you have seen Kennedy um with his shirt off, because he likes to do, I mean, I think he's in his early 70s. Uh uh, he is very fit. Uh, he is certainly interested in the in this space and specifically peptides. In fact, he was just on Joe Rogan talking about peptides, and and he talked about how he takes peptides himself and how he you know experienced you know benefits. So, as you said, uh Taryn, there are uh thousands of these peptides. And, you know, we know of, I don't know, probably if we sat down and and worked really hard, we could probably write down maybe 50, maybe a hundred together between the two of us. Um, there are a lot of different peptides that are on the market, have been on the market for a long time that help people. And the challenge that happens is you have government agencies like the Food and Drug Administration, which their you know kind of main purpose really is to protect the American public, right? They're their their job is to make sure that the the food and the drugs that are uh you know here in uh in the United States are ultimately safe for us, right? And they have different processes by by how they look at that. So a lot of the peptides that exist today, um, you had mentioned some of the branded drugs. You know, those drug companies go through years and years, uh, sometimes decades of research and billions of dollars of research. And there's really kind of a couple different ways they look at it, but you know, the two big ones is safety and efficacy. You know, is it gonna be safe for you? Uh is it gonna be efficacious? And when they look at safety, they also look at, you know, the risk reward, right? Because there's always gonna be some sort of contraindication to every sort of medication. So when they're making drugs and when the FDA approves drugs, they say, okay, does the reward outweigh the risk? And if it does, and it goes through a it goes through the processes that it needs to go through through the FDA, which sometimes again takes years of approval, then it becomes you know a commercial drug. A lot of these peptides have not gone through that process. Um, and that's where it's starting to become confusing for people uh and and what's next. Um, there's a lot of talk right now because Joe Rogan was just on on on, excuse me, uh uh Kennedy was just on Joe Rogan and he's talking about all these peptides, and he was saying that, hey, what you know, we really want to give people access to it. And that now has turned into what I would say complete chaos on the internet uh in in in the United States saying that all these peptides are now going to be available. And that's just, I don't believe that that's the case.

SPEAKER_02 10:02

Which brings me to peptides. Like where where are we at right now on peptides and getting them regulated and making sure it's not this weird gray area because we know they're effective.

SPEAKER_00 10:14

What happened was there were 19 peptides that were widely formulated by compounding pharmacies during the Biden administration. They illegally moved those to category two, which says do not formulate. What happened? There was huge demand for peptides. And so a black market came out, and a lot of this stuff that we've looked at is just, you know, is very, very substandard. I'm very anxious to move, not probably not all of those peptides, some of them are in litigation, uh, but about 14 of them back to making them more accessible. And within a couple of weeks, we will have announced uh some kind of new action.

SPEAKER_01 11:01

So what do you think what would be the circumstances under which some of these research peptides would become legal, if that's the right word, or more widely available? How how would that work, do you think? And you know, what what do you think the timeline for that would be?

SPEAKER_03 11:24

Yeah, so it, you know, if you go through now, uh I'm an attorney, not necessarily in this space, but you know, I have grown up in the in the dietary supplement space, so there's a there's a lot of kind of crossover there. Um when you're talking about prescriptions, it's a much more rigorous process, right? Uh, you know uh in all reality, as we sit here today, if there was a we'll call it what they call a new dietary ingredient or a new drug application in the world of pharmaceuticals, it's years before it actually becomes available where the average everyday person could either get a prescription for it or they could somehow get access to it. It's years. And a lot of the peptides that people are interested in, like you had mentioned BPC 157, TB500, you didn't say about CJC, there's AOD, GHK, there's a lot of these peptides that people are taking, including me, right? Uh on a daily on a daily basis, that people want access to. And what Kennedy is trying to do is he's trying to make it so that it's safer. And so generally, uh, when a new drug is brought to market, it's years. And what Kennedy is trying to do is trying to effectively bypass the process and which the FDA has had in place, which I just don't think is possible. Hold on, it's not that it's not possible, I just don't think it's going to happen. And I think because you don't you don't think it's probable. I don't think it's probable because the safety part of it, right? Um, if there were 15 peptides that were just unilaterally allowed to be compounded, that's what he's talking about, overnight, right? And God forbid somebody gets sick and dies, right? Now we have a real problem, you know. Uh, and and I I just I just don't see the FDA being pressured by Kennedy or anybody for that matter to allow that to happen. And you know what? As somebody who injects this stuff every day and who is a proponent of access and health and wellness, I believe that that's the right course of action. I believe that the FDA should take a little bit of time and not just say, okay, you know, this stuff can be available to everybody.

SPEAKER_01 13:40

Now, when you listen to Joe Rogan or when you read some of the articles around RFK's thinking about research peptides. And again, research peptides are peptides that are for research purposes only. You know, we're not talking about uh GLP1s, we're not talking about weight loss drugs, we're not talking about approved. These are these very clearly on the bottle say for research only. And some of the ones that you mentioned, it sounds a lot like alphabet soup for people that are less familiar with this world, right? BPC 157, TB500, AOD, right? Um, but when you listen to RFK's argument, it sounds like he's got this thing handled. Like, you know, it there's there's a there's a picture that I think is painted for me when I listen to him talk on an episode like Joe Rogan. So walk us through a little bit, like what is RFK's thinking and reasoning around how peptides could become fairly readily available in a way that the FDA might corroborate this.

SPEAKER_03 14:52

So here's the here's the biggest concern I think he has, and it's what it's what he said, and and it's it's the right place to start, right? One, he has personal experience of it. So if you have personal experience, you're gonna probably be a little bit more passionate about it. But he's really he is concerned about safety. So a lot of these peptides, and he did say this on on Gerald Rogan show, and and quite frankly, most pharmaceutical drugs, the the active pharmaceutical ingredient, in other words, the base of a lot of these drugs, they're made outside of this country. They're made in China, they're made in India, right? They're just they they just are. And then when they come into this country, that's when things change, right? That's when different labs, third-party labs, drug manufacturers are testing it. They're running it through a battery of stability tests, sterility tests, they're making sure there's no endotoxins, no, no uh, you know, um uh you know, no heavy metals and things, they're just making sure that it's it that it's that it's at least as pure as it possibly can be. So that's his first kind of, I believe, thought process. We want to make sure that the stuff that's coming into the United States is safe. Because when you have um demand, there's going to be bad actors, right? So right now, with these research peptides, as you said, they're not illegal to possess, they're not even illegal to sell, right? Um, but it but what becomes, quote, illegal is how they're sold. In other words, what they're saying about them. So a lot of bad actors out there are saying, hey, if you take this peptide and you have XYZ disease, it's gonna be cured. That's that's when the FDA starts to get concerned. That's when the Federal Trade Commission starts to get concerned, that's when the different uh boards of pharmacies start to get to get concerned. And that I believe that's where Kennedy is starting. So I think the one of the things that Kennedy is trying to do is like, hey, these manufacturers from outside the United States that are shipping straight into the United States into an average consumer's hands, that's what I want to stop. That's the one thing I think, you know, where he's where he's headed. And I think that's I think that can be done quickly, that can be done pretty quickly, right? And so um if if I was a consumer right now, and you're hearing about this, you're watching Joe Rogan, you listen to Joe Rogan, and maybe you heard about these things, or maybe you're on a podcast like ours, because we've had some people talk about this stuff. You and I have talked about this stuff before. And let's say you wanted to get it today, you're like, oh, BPC 157 sounds really interesting to me. Well, there's there there's there's a lot of things that the average consumer could do, but the biggest thing is is trust, right? And how do you how do you trust? How do you really know? How can you really trust these companies? Well, um, when you buy anything, even a dietary supplement or or or a lot of food sometimes as well, but it's usually a dietary supplement and certainly a drug, you can get what they call uh a certificate of analysis, right? And that certificate analysis is gonna tell you all those things that I just mentioned, right? Ultimately, it's gonna tell you whether or not it's pure, right? It'll tell you where it's made and it'll tell you where it's processed. Now, that in and of itself isn't also the end-all be-all. If you really want to be safe, and there are companies out there, and Taryn, you and I um met an old friend of yours that uh that has a um another friend who has a company that does this, you can literally take the vial that you get. Like if you get something from a website and you want to try it, buy three vials, take one, send it to a third-party lab, have them test it before you do anything with it. I think that's kind of like one of the safest things uh to do. But ultimately to answer your question, you know, what he's trying to do at first, I think he's really trying to make the supply safe.

SPEAKER_01 18:12

So that leads me to the next question, which is if while these aren't legal, but it's not illegal to possess them, it's not even illegal to sell them. Um is there a problem with accessibility or what is RFK trying to address through his agenda of legalization when right now you can get these peptides, you can inject these peptides, and um there is a level of access and affordability that exists today. What is he trying to influence here?

SPEAKER_03 18:49

I think I think what he believes is that by controlling the the base ingredient, the active pharmaceutical cool ingredient, starting there, and then allowing it to be compounded, made at quote reputable compound pharmacies. I believe that he believes that that will improve the safety for the average, you know, uh consumer. So I think what he's trying to influence is he's trying to influence the FDA to have the FDA ultimately say that these are available to be compounded. The challenge, and Taryn, you and I talk about this all the time. I could go down a rabbit hole for a long period of time from the from a legal perspective, but the challenge with that is is the speed and which that can be done, right? It it just can't be done correctly uh within a couple weeks. Now, we saw what happened with COVID and how things got you know sped up quite quickly, and lo and behold, guess what? You know, there's all sorts of problems with vaccines that were that were rushed through. Shocker, okay? So, what I think ultimately his influence is going to do, which I think will be good for people, right, as long as they can educate themselves. What I think is going to happen is because the rate the FDA does have a process, there are certain steps that just need to be followed, from safety to efficacy to uh to um you know animal trials to human trials, there's a lot of things that need to be done, and it just takes time. There are a bunch of peptides that do have history of use, right? They have history of safety. Most of it's anecdotal, though, right? There's not actual human studies. They're just people have been using it for years. When I look at the dietary supplement space, a lot of dietary supplements are like that as well. They're just people have been taking them for years, right? So, what I think is going to happen is the FDA is gonna do something, it's called enforcement discretion. I think the FDA is probably gonna issue some sort of letter, right? Or some sort of guidance and say, ultimately, we're not gonna come after you, compound pharmacies, if you just do these things, right? If you just make sure that the active pharmaceutical ingredient is tested, that you make sure that you're not saying certain things, and that you're just giving some basic guidance. That in and of itself changes the way the FDA has operated since 1933, when I believe the FDA was actually, you know, became an agency.

SPEAKER_01 21:13

Um, so let's let's back up for just a moment because you talked about animal models, you talked about human models, these peptides that are classified for research purposes only, and this is really important. Mike, how much research has been conducted on what these research-only peptides do inside the human body?

SPEAKER_03 21:42

Well, it depends on the peptide itself that we're talking about. Some of these have zero research as it relates to safety. I mean zero. And someone would say, Well, why? Like, how is this even how is this stuff even available? Why would anybody even inject it in themselves? Like, it doesn't even make any sense. Like, how could anybody inject something in their body that has zero safety studies as it relates to humans consuming it? And and I I have the same question like, how is that even possible, right? Well, so it's possible because of what we call anecdotal data, right? Or or also lack of what Kennedy said, lack of safety signals. In other words, there hasn't been any reports of what they call adverse events. So people are just putting putting it in their body, nobody's gotten sick, right? And so a lot of these research peptides are classified as research peptides because ultimately it's just a loophole. That's really what we're talking about, right? And I'll just I wanted to say one thing about research peptides. So you have what they call research grade material, right? It's a similar analysis or similar way to look at it as um pet food, right? Uh versus human-grade food, right? A lot of the pet food is made with the same kind of base ingredients, chicken, beef, things like that, but it but a lot of the pet food is byproducts. It's stuff that humans wouldn't necessarily want to consume. And then human food is actually the actual chicken. It's not the bones, it's not the, you know, it's not the fat, it's it's it's the actual meat itself, right? So you have that that would be considered the the pet food is research grade, right? And then you have research, you know, there you you have a classified something that's classified as a as a research peptide. There's actually a small distinction there, research grade and a research peptide. The second is just how companies are classifying it so they can get around some of the FDA regulations. It doesn't make it an inferior product. That's the difference. You could have a research peptide that is 99% pure, that has gone through all the safety and efficacy studies and research that we've just talked about. You could have a peptide that does that and still be considered a research peptide because it ultimately hasn't been approved by the FDA. So I think ultimately, you know, what Kennedy is trying to do is trying to speed up the process to make some of these things easier. Ultimately, again, I think it's going to be enforcement discretion, and I think we're going to see a slow rollout. There's going to be some peptides that do, in fact, have clinical data, history of use, safety and efficacy studies on humans already that have been, you know, um banned, so to speak, that are going to be put back on. That's where I see uh things happening. I don't see some of these ones, even like the ones that we like, BPC or what have you, just uh unilaterally being able to be compounded uh without any sort of uh oversight.

SPEAKER_01 24:40

Do we know what peptides have research and efficacy behind them?

SPEAKER_03 24:47

Yeah, so uh there are some that have been like so um I believe CJC1295 is one of them, uh, or uh ipamorlin, uh I believe uh Kisapeptin, I think. Uh those three, I might be wrong on CJC, but uh Ipamoralin and Kisapeptin, I'm sure, have been uh used before, and then they were they were um they they were taken, they were put into a category, which by the way doesn't exist anymore, what they call category two, which basically means you can't compound them, right? Because there were some safety issues. But both of those have been commercially available before. Uh, I believe that those two will probably get um put back on and allowed to be compounded and maybe maybe just on some a much uh tighter safety uh uh protocol. Um Ipamoralin, I believe, uh was uh was a drug, uh a commercial drug that was used to help with muscle wasting in HIV and AIDS patients, right? But then there were some safety issues, and so they put it back in in category two. I think there's there's probably a way to tighten up the safety uh standards for it. Uh for in other words, making sure that the class of people that do take it fall within a certain category because of that whole risk reward, because there still is going to be a safety risk, and whether or not the the the reward outweighs the risk is something that a clinical provider or doctor is gonna have to determine.

SPEAKER_01 26:17

Um okay, so really uh sort of my last question and bringing this down to the level of the consumer, to our audience, to our listeners, uh for folks that are listening to this right now that are like, okay, that's a really interesting analysis. Um maybe I am taking some research peptides, maybe I'm research peptide curious, uh, maybe I want to look more into this and think about what it can do for me or members of my family. Um, how am I, how should I be thinking about this as a consumer? And what does sort of the potential existing legal landscape for me, what does that mean for me and my access?

SPEAKER_03 27:01

So if you're curious, I mean, so here we are in early March. Um I'm pretty sure we're gonna release this in March. So here we are in March of 2026. Uh and you know, if it's a little bit later, hopefully it's not, but let's look, we're it's March of 2026. Uh, I'd give it a little bit of time and just see, just, just see what what the FDA uh is going to do. I'm very confident that I can could be wrong, lawyers always give themselves a little out, but I'm very confident that the FDA is not just going to just wholesale say, here, here are all these peptides, go ahead and make them have have at it. I don't think that's going to happen. That would just, again, it would completely change the the the entire landscape of the food and drug administration. I think they're going to again exercise enforcement discretion, which means we're not going to do anything, right? So as a consumer, I give it a little bit of time. If you're really curious uh and you wanna and you wanna try it, I think look, uh, you know this, right? So um I inject research peptides every single day. Not research grade, research peptide peptides every single day. I give my father, you know, uh research peptides, right? So I'm a believer in the safety and the efficacy of these things. And anecdotally, uh for me and for my father and for for others that I that I know and love, it it helps, you know, it helps them. If if I were gonna give anybody any sort of advice, and again, you have to be really careful, I'm not giving you legal advice, I'm not qualified to give you legal advice, so don't take this as any sort of legal or medical advice. But if I had a friend and they asked me, hey, I want to take this stuff, what should I do? Well, one, you find a company that maybe someone else that you know knows and likes and have had some success with it. I would start there, just like anything else, right? Two, I would look at the company and I would look at what sort of documentation do they have that can provide you with a level of comfort that the product itself is made at the highest standard possible here in the United States, right? It's made right here in the United States, it's tested right here in the United States. Then I would see whether or not it's been third party tested, right? So an independent third-party company tested, and you would get that through a what they call a certificate of analysis. That's that's a pretty high level of trust. Can that be manipulated? Yes, but that's okay. Let's let's assume that it's not, right? For that. And then the last thing I would do if you want to be ultimately safe for yourself, right? Is if you're going to try something, again, I'm not a doctor. I'm uh uh I can't give you medical advice, but I'm talking to you as if you're you're as if you're my friend. I would buy three bottles, I would take one, I would send it to an independent third-party lab, have it tested for all the things we just talked about. And then if you decide that you feel comfortable with it, then you can try and and you know and see if it you know see if it works for you. That's what I that's how I would look at it uh as a consumer. I'm gonna say it one more time. I'm not a doctor and I'm not giving any sort of medical advice.

SPEAKER_01 30:03

That's or or legal advice.

SPEAKER_03 30:06

Or legal advice. Sorry, I'm gonna have to write this up in disclaimers and and look, I think I know I know we don't have a lot of time, but as you and I both know, this is a it's it's a really interesting time to be alive. Uh, it's a really interesting time to be in this space in health and longevity. Because as uh you, you know, if you take a look at my Instagram, I talked about this. I am a proponent of like we're talking about this stuff, you're a proponent of this stuff. We we see the benefits, right? And the reason why we have the Better Body Lab podcast is because we want to continue to give people the best information that we possibly can. And so there are some really, really great benefits to a lot of these things. And I hope that um as the information continues to come out that people educate themselves as best they can, and then ultimately they make the decision on their own for what's best for them.

SPEAKER_01 30:54

So yeah, that's great. Um, maybe we can put in the show notes also where we get our peptides and also suggest a company for third-party testing. We'll put that in there as well.

SPEAKER_03 31:05

Yeah, we do we definitely do know of some great companies. We'll probably give you a few that we're that we feel really good about. And then that other company we talked about, they test this stuff, you know? So yeah, that's a great idea, great idea.

SPEAKER_01 31:18

All right. Well, thanks for tuning in to the Better Body Lab podcast with Mike Alden and Dr. Taryn Marie. We're gonna put in the show notes a couple of things just to help you kind of navigate this space, uh, including where we get our peptides. Um, also a company that you can send any peptides that you have or your family members have to get third-party testing to understand what is actually in uh that little vial. And uh thanks for thanks for tuning in today. We're excited to be on the forefront of this conversation. We really see a lot changing in this uh research peptides area, and we're excited to walk you through this, answer questions that you have, and provide guidance. Thanks everyone. Until next time, this is the Better Body Lab Podcast with Dr. Taryn Murray and Mike Alden.